DuBiotech Promotes Public Sector Life Science Initiatives at BIO 2015

DUBAI, United Arab Emirates, June 17, 2015 /PRNewswire/ -- Spotlighting the United Arab Emirates' (U.A.E.) burgeoning role as a global facilitator and hub for life sciences companies, DuBiotech Executive Director Marwan Abdulaziz Janahi this week outlined various sector initiatives aimed at attracting international companies to the Middle East and North Africa (MENA) region. Mr. Janahi's remarks were made during a key panel discussion at BIO 2015, the Biotechnology Industry Organization's premier global event for the biotechnology sector.

"No other place in the world can match the incentives, infrastructure, and facilities that the UAE can offer biotech companies today," said Mr. Janahi. "DuBiotech has proved a landmark investment in making the UAE an international centre for biotech innovation. With over 25 per cent new business partner growth in 2014, more companies are realising the benefits of doing business in the UAE and using our facilities to access the MENA region and beyond."

DuBiotech, a member of TECOM Investments, is dedicated to fostering the growth of the life sciences industry. It provides business partners with technical expertise and essential infrastructure, while its close proximity to strategic regional markets makes it an ideal location for businesses targeting the Middle East. DuBiotech also provides business partners with numerous free zone benefits such as 100 percent foreign ownership, zero percent tax, full repatriation of profits and capital, and customs duty exemption for goods and services.

Since its inception in 2005, and supported by investment of over $400 million, DuBiotech has developed unmatched infrastructure and cutting-edge research and development facilities for industries including biotechnology, pharmaceutical, medical and scientific devices, as well as the food and agricultural sector. Through this, DuBiotech provides a state-of-the-art base for companies looking to capitalize on the significant growth opportunities that exist in the Middle East.

Some of DuBiotech's world-renowned biotechnology, pharmaceutical, and research business partners include Pfizer, B.Braun, Thermo Fisher, Amgen, Merck Serono, and Medtronic.

The BIO International Convention is the largest gathering of the global biotechnology industry, hosted by the Biotechnology Industry Organization (BIO). BIO is the world's biggest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations.

For further information on DuBiotech or TECOM Investments, contact:

Iain Munro, Bell Pottinger 
Mobile: +971 555597389 
Email: [email protected]

About DuBiotech

Dubai Biotechnology and Research Park (DuBiotech), a member of TECOM Investments, is a freezone business park dedicated to fostering the growth of the life sciences industry in the region. DuBiotech was established to support the Government of Dubai's vision to transform the UAE into a knowledge-based economy and develop the region's talent pool.

DuBiotech offers world-class infrastructure and cutting edge research and development facilities, specifically designed and built for the field of biotechnology, pharmaceutical, medical and scientific device, food and agricultural industries. The freezone can support both start-ups and international firms looking for a regional base for their Middle East or global operations. The park is central to a community that is committed to the industry's success by bringing together business, regulators and Government in partnership.

Since its launch in 2005, DuBiotech has rapidly grown into a community of more than 195 life sciences companies such as Pfizer,  Merck-Serono, Amgen, Bristol-Myers Squibb, Maquet, National Reference Lab, ThermoFisher, Bayer, Mylan, Firmenich and IFF. 

For further information on DuBiotech, please visit our website: www.dubiotech.ae.

SOURCE DuBiotech